Metformin-based therapy should be first-line treatment for patients with type 2 diabetes at low cardiovascular risk

A comparison of glucose-lowering drugs suggests that metformin-based therapy may be a preferred first-line treatment for drug-naive patients with type 2 diabetes at low cardiovascular risk. There is not enough evidence to reach a conclusion about the optimal initial treatment of drug-naive patients at increased cardiovascular risk. Findings from a systematic review and network meta-analysis are published in Annals of Internal Medicine.

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *